RD114-pseudotyped oncoretroviral vectors. Biological and physical properties
- PMID: 11458516
RD114-pseudotyped oncoretroviral vectors. Biological and physical properties
Abstract
Limited functional expression of the viral envelope receptor is a recognized barrier to efficient oncoretroviral mediated gene transfer. To circumvent this barrier we evaluated a number of envelope proteins with respect to gene transfer efficiency into primitive human hematopoietic stem cell populations. We observed that oncoretroviral vectors pseudotyped with the envelope protein of feline endogenous virus (RD114) could efficiently transduce human repopulating cells capable of establishing multilineage hematopoiesis in immunodeficient mice after a single exposure to RD114-pseudotyped vector. Comparable rates of gene transfer with amphotropic and GALV-pseudotyped vectors have been reported, but only after multiple exposures to the viral supernatant. Oncoretroviral vectors pseudotyped with the RD114 or the amphotropic envelopes had similar stability in vitro, indicating that the increased efficiency in gene transfer is at the receptor level likely due to increased receptor expression or an increased receptor affinity for the RD114 envelope. We also found that RD114-pseudotype vectors can be efficiently concentrated, thereby removing any adverse effects of the conditioned media to the long-term repopulating potential of the target human hematopoietic stem cell. These studies demonstrate the potential of RD114-pseudotyped vectors for clinical use.
Similar articles
-
Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells.Mol Ther. 2005 Mar;11(3):452-9. doi: 10.1016/j.ymthe.2004.10.014. Mol Ther. 2005. PMID: 15727942
-
Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector.Hum Gene Ther. 2002 Jul 20;13(11):1317-30. doi: 10.1089/104303402760128540. Hum Gene Ther. 2002. PMID: 12162814
-
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.Hum Gene Ther. 2007 Sep;18(9):811-20. doi: 10.1089/hum.2006.138. Hum Gene Ther. 2007. PMID: 17824830
-
[Insertion of genetic material into the hematopoietic cells of mammals].Ontogenez. 1985 Nov-Dec;16(6):547-52. Ontogenez. 1985. PMID: 2868439 Review. Russian. No abstract available.
-
Gene therapy utilizing drug resistance genes: a review.Stem Cells. 1994 Jul;12(4):378-85. doi: 10.1002/stem.5530120404. Stem Cells. 1994. PMID: 7951004 Review.
Cited by
-
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.Blood. 2007 Oct 15;110(8):2793-802. doi: 10.1182/blood-2007-02-072843. Epub 2007 Jul 17. Blood. 2007. PMID: 17638856 Free PMC article.
-
Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transduction.Methods Mol Biol. 2009;538:263-85. doi: 10.1007/978-1-59745-418-6_13. Methods Mol Biol. 2009. PMID: 19277588 Free PMC article.
-
Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platform.Sci Adv. 2024 Feb 16;10(7):eadj2445. doi: 10.1126/sciadv.adj2445. Epub 2024 Feb 14. Sci Adv. 2024. PMID: 38354234 Free PMC article.
-
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.Cancer Immunol Res. 2019 Mar;7(3):363-375. doi: 10.1158/2326-6066.CIR-18-0572. Epub 2019 Jan 16. Cancer Immunol Res. 2019. PMID: 30651290 Free PMC article.
-
Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturing.Mol Ther Methods Clin Dev. 2022 Dec 9;28:116-128. doi: 10.1016/j.omtm.2022.12.006. eCollection 2023 Mar 9. Mol Ther Methods Clin Dev. 2022. PMID: 36620071 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical